Connecting you to content on EBSCOhost

Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 11

Results: 6

1

Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes Mellitus.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 11, p. 849, doi. 10.1007/s40261-024-01405-8

By:

Westergaard, Lisbet;
Alifrangis, Lene;
Buckley, Stephen T.;
Coester, Hans Veit;
Klitgaard, Thomas;
Kristensen, Niels R.;
Nishimura, Erica;
Nørgreen, Lea;
Rocha, Thaís M. P.;
Steensgaard, Dorte B.;
Vegge, Andreas;
Plum-Mörschel, Leona

Publication type:

Article

2

A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 11, p. 839, doi. 10.1007/s40261-024-01403-w

By:

Mokhtare, Marjan;
Fathi, Maryam;
Sadeghian, Amir M.;
Sotoudeheian, Mohammad-Javad;
Namazi, Abolfazl

Publication type:

Article

3

Diagnosis and Management of Drug-Induced Interstitial Lung Disease in the context of Anti-Cancer Therapy: a Multidisciplinary Viewpoint by Portuguese Experts.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 11, p. 801, doi. 10.1007/s40261-024-01400-z

By:

Fontes e Sousa, Mário;
Campainha, Sérgio;
Marques, Inês Dias;
Dinis, Rui;
Inácio, João Rodrigues;
Mendes, João João;
Luís, Rita;
Ferreira, Ana Magalhães;
Racha-Pacheco, Ricardo;
Rolo, Rui;
Sousa, Gabriela;
Cortes, Paulo

Publication type:

Article

4

Cost-Effectiveness of Empagliflozin (JARDIANCE<sup>®</sup>) in the Treatment of Patients with Chronic Kidney Disease in France, Based on the EMPA-KIDNEY Clinical Trial.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 11, p. 811, doi. 10.1007/s40261-024-01398-4

By:

Groyer, Harinala;
Supiot, Romain;
Tardu, Jean;
Virely, Nicolas;
Sivignon, Marine;
San, Denis;
Lévy, Pierre;
Ustyugova, Anastasia;
Massy, Ziad A.

Publication type:

Article

5

Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 11, p. 829, doi. 10.1007/s40261-024-01397-5

By:

Aguirre, Clara;
Alonso-Torres, Ana;
Agüera, Eduardo;
García-Domínguez, José Manuel;
Montero-Escribano, Paloma;
González-Quintanilla, Vicente;
Costa-Frossard, Lucienne;
Oreja-Guevara, Celia;
Reyes-Garrido, Virginia;
Caminero-Rodríguez, Ana Belén;
Riancho, Javier;
Sánchez, Octavio;
Forero, Lucía;
Pérez-Parra, Fernando;
Ares-Luque, Adrián;
Téllez, Nieves;
Arzalluz-Luque, Joaquín;
Iglesias, Federico;
Casado-Ruiz, Virginia;
Castellano-Vicente, Alberto José

Publication type:

Article

6

Pharmacokinetics and Tolerability of the Novel Myeloperoxidase Inhibitor Mitiperstat in Healthy Japanese and Chinese Volunteers.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 11, p. 863, doi. 10.1007/s40261-024-01402-x

By:

Sunnåker, Mikael;
Bhattacharya, Chandrali;
Nelander, Karin;
Aurell, Malin;
Heijer, Maria;
Collén, Anna;
Han, David;
Holden, Julie;
Trebski, Monika;
Garkaviy, Pavlo;
Ericsson, Hans

Publication type:

Article